Glancy Prongay & Murray & Erasca

Glancy Prongay & Murray: Glancy Prongay & Murray is a shareholder rights law firm that has commenced an investigation and lawsuit against Erasca for possible violations of federal securities laws.

Erasca: Erasca is the defendant in multiple class action lawsuits alleging securities fraud due to misleading statements about its drug candidate ERAS-0015, patent infringement claims, and a patient death during clinical trials. This has led to a significant drop in its stock price and market capitalization.

Glancy Prongay & Murray: Glancy Prongay & Murray is a law firm that urged shareholders to contact them about the securities fraud lawsuit.

Erasca: Erasca is the defendant in the securities class action, accused of misleading investors about ERAS-0015. Its stock collapsed over 45% following disclosures of patent disputes and a patient death, erasing billions in market value.